DARTEMPA®
Brand Name:
-
Dartempa 10/25 Tablets
Composition: Empagliflozin 10/25mgPacking: 1x10 -
Dartempa-L 10/5 & 25/5 Tablets
Composition: Empagliflozin 10/25mg + Linagliptin 5mgPacking: 1x10
INDICATED IN:
Type II Diabetes Mellitus patients with Cardiovascular Risk
Mode of Action
-
Empagliflozin
Empagliflozin belongs to a class of medicines called SGLT2 (sodium glucose transporter 2) inhibitor. SGLT2 channel mainly present in kidney (nephron) responsible for the 90% glucose reabsorption in the body. Empagliflozin blocks SGLT2 channel & decreases the reabsorption of glucose, increases glucose excretion through urine -
Linagliptin
Linagliptin is a DPP4 Inhibitor which reduces the amount of glucose produced by the liver, by raising insulin levels and decreasing the levels of the glucagon (the hormone that increases blood glucose level).
Benefits & Usage
Empagliflozin is well-tolerated and safe as noted in older patients, patients with poorly controlled diabetes, those with heart failure or CV risk factors. Empagliflozin also improves glycemic control in patients with poorly controlled T2DM.
Precautions
Alcohol
It is unsafe to consume alcohol with Dartempa Tablets, Dartempa-L Tablets.
Pregnancy
Make sure your doctor knows if you are pregnant or planning to become pregnant.
Medicine
Do not take other medicines unless they have been discussed with your doctor.
Liver & Kidney
Should be used with caution in patients with liver & kidney disease.
